Esophagogastric Cancer Case Discussions

Esophagogastric Cancer Case Discussions

Did you know that there are now several biomarkers that can be used to guide immunotherapy choice for esophagogastric cancers? Join Drs. Shah and Uboha in a discussion on the latest in the field for immunotherapy treatment in esophogogastric cancer.
 

This activity is intended for oncologists, gastroenterologists, and pathologists on the esophagogastric cancer care team.
 

The goal of this activity is to enable clinicians in integrating immune checkpoint inhibitor (ICI)-based regimens for esophagogastric cancer in different treatment settings, including first-line and later for metastatic disease and adjuvant treatment.
 


Learning Objectives:

Upon completion of this activity, participants will:

  • Have increased knowledge regarding the
    • Clinical evidence on the use of ICIs in esophagogastric cancers
    • Role of biomarkers in treatment planning for ICI therapy in esophagogastric cancers
  • Have greater competence related to
    • Incorporating ICI therapy as treatment for esophagogastric cancer
  • Demonstrate greater confidence in their ability to
    • Individualizing ICI therapy as treatment for esophagogastric cancer

Approximate Time to Complete: 15 minutes

 

Credit Available: March 24, 2022 - March 24, 2023

 

Developed through a partnership between SITC and Medscape.

sitc_log_color.png     

Medscape_EDU-RGB-2x-300.png

 

 

Additional Resources for Clinicans from SITC:

 

 

Course Objectives
Upon completion of this activity, participants will be able to:
  • Have increased knowledge regarding clinical evidence on the use of ICIs in esophagogastric cancers.
  • Have increased knowledge regarding the role of biomarkers in treatment planning for ICI therapy in esophagogastric cancers.
  • Demonstrate greater confidence in the ability to individualize ICI therapy as treatment for esophagogastric cancer.
  • Have increased knowledge regarding incorporating ICI therapy as treatment for esophagogastric cancer.
Accreditation Council for Continuing Medical Education (MD/DO)
AMA PRA Category 1 Credit(s)™: 0.50
Accreditation Council for Continuing Medical Education and ABIM Maintenance of Certification
AMA PRA Category 1 Credit(s)™ / ABIM Maintenance of Certification Part 2 Credit: 0.50